Clinical Review
Tesamorelin
Tesamorelin stimulates growth hormone signaling. FDA-approved tesamorelin has a specific indication; other goals d...
View optionClear Stream Health
InvestigationalCJC-1295
Growth hormone-releasing hormone analogue
CJC-1295 is studied for its effect on growth hormone signaling. Claims involving muscle, fat loss, sleep, or recovery remain subject to evidence, safety, and regulatory limitations.
Treatment details
What’s included
Clinical consultation, medical-history and medication review, eligibility assessment, discussion of regulatory status and alternatives, and ongoing monitoring when appropriate.
Clinical & Availability Review
Office: 2874 Route 94, Washingtonville, NY 10992
Appointments
Monday through Saturday from 1:00 PM to 6:00 PM.
Mobile infusion appointments are available Monday through Saturday from 9:00 AM to 8:00 PM.
This item is listed for education. It is not represented as an available or FDA-approved treatment.
Explore more
Related peptide options
Clinical Review
Clinical Review
Ipamorelin
Ipamorelin is discussed in investigational wellness settings for growth hormone signaling, body composition, sleep...
View option
Investigational
IGF-1 LR3
IGF-1 LR3 is an investigational analogue discussed in research contexts involving muscle and metabolic signaling....
View option